Centro de Saúde Lavadores, Gerencia de Gestión Integrada de Vigo, Servicio Galego de Saúde, Vigo, España.
Centro de Salud Auxiliar de Chile, Área Hospital Clínic-Malvarrosa, Valencia, España.
Gastroenterol Hepatol. 2022 Feb;45(2):106-113. doi: 10.1016/j.gastrohep.2021.04.001. Epub 2021 May 21.
Colorectal cancer 5-years-survival is 57%, partway due to a low rate of participation in screening programmes. Instruments analyzing causes of low adherence are needed.
To evaluate the validity and internal consistency of the Spanish version of Rawl's Questionnaire for the screening of colorectal cancer by faecal occult blood testing.
Questionnaire validation methodology.
Three Primary Care Centres in Valencia.
Age, sex, civil status, educational level, social class, smoking, alcohol consumption, body mass index, personal and family history of cancer.
We analyzed 408 individuals (237 cases and 171 controls). Mean age was 59.45 years (SD 5.17). Internal consistency of all variables reached a Cronbach's alfa of 0.796. The Cronbach's alfa benefit dimension of the screening was 0.871 and for the barrier dimension of the screening it was 0.817. Intraclass correlation coefficients of the test-retest for the benefit dimension of the screening was 0.809 (CI 95% 0.606-0.913) and 0.499 (CI 95% 0.126-0.750) for the barrier dimension.
The Spanish version of Rawl's Questionnaire is valid, reliable and reproducible, so we have this validated instrument with which to identify barriers and benefits in a colorectal screening programme in Spain.
结直肠癌的 5 年生存率为 57%,部分原因是参与筛查计划的比例较低。需要分析导致低依从性的原因的工具。
评估粪便潜血检测结直肠癌筛查用 Rawl's 问卷的西班牙语版本的有效性和内部一致性。
问卷验证方法。
瓦伦西亚的三个初级保健中心。
年龄、性别、婚姻状况、教育水平、社会阶层、吸烟、饮酒、体重指数、个人和家族癌症史。
我们分析了 408 个人(237 例病例和 171 例对照)。平均年龄为 59.45 岁(SD 5.17)。所有变量的内部一致性达到 Cronbach's alfa 为 0.796。筛查的受益维度的 Cronbach's alfa 为 0.871,而筛查的障碍维度的 Cronbach's alfa 为 0.817。筛查受益维度的测试-重测的组内相关系数为 0.809(95%CI 0.606-0.913),而筛查障碍维度的组内相关系数为 0.499(95%CI 0.126-0.750)。
西班牙版 Rawl's 问卷具有有效性、可靠性和可重复性,因此我们有了这个经过验证的工具,可以在西班牙的结直肠癌筛查计划中识别障碍和获益。